Logo image of ITI

Iteris Incorporated New (ITI) Stock Fundamental Analysis

NASDAQ:ITI - Nasdaq - US46564T1079 - Common Stock - Currency: USD

7.19  -0.01 (-0.14%)

Premarket: 7.19 0 (0%)

Fundamental Rating

5

Overall ITI gets a fundamental rating of 5 out of 10. We evaluated ITI against 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and the financial health of ITI get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, ITI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ITI was profitable.
ITI had a positive operating cash flow in the past year.
In multiple years ITI reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ITI reported negative operating cash flow in multiple years.
ITI Yearly Net Income VS EBIT VS OCF VS FCFITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ITI has a Return On Assets of 1.12%. This is comparable to the rest of the industry: ITI outperforms 54.84% of its industry peers.
Looking at the Return On Equity, with a value of 1.99%, ITI is in line with its industry, outperforming 55.65% of the companies in the same industry.
ITI has a Return On Invested Capital (1.26%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.12%
ROE 1.99%
ROIC 1.26%
ROA(3y)-5.51%
ROA(5y)-2.81%
ROE(3y)-9.55%
ROE(5y)-4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ITI Yearly ROA, ROE, ROICITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Profit Margin of ITI (0.80%) is comparable to the rest of the industry.
ITI's Profit Margin has declined in the last couple of years.
ITI has a Operating Margin of 0.64%. This is comparable to the rest of the industry: ITI outperforms 51.61% of its industry peers.
ITI's Operating Margin has improved in the last couple of years.
ITI has a better Gross Margin (37.38%) than 63.71% of its industry peers.
ITI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.64%
PM (TTM) 0.8%
GM 37.38%
OM growth 3Y11.09%
OM growth 5YN/A
PM growth 3Y-40.46%
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5Y-0.15%
ITI Yearly Profit, Operating, Gross MarginsITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ITI is destroying value.
The number of shares outstanding for ITI has been increased compared to 1 year ago.
Compared to 5 years ago, ITI has more shares outstanding
There is no outstanding debt for ITI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ITI Yearly Shares OutstandingITI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ITI Yearly Total Debt VS Total AssetsITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ITI has an Altman-Z score of 3.69. This indicates that ITI is financially healthy and has little risk of bankruptcy at the moment.
ITI has a Altman-Z score of 3.69. This is in the better half of the industry: ITI outperforms 62.10% of its industry peers.
ITI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.69
ROIC/WACC0.13
WACC9.39%
ITI Yearly LT Debt VS Equity VS FCFITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ITI has a Current Ratio of 1.77. This is a normal value and indicates that ITI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ITI (1.77) is worse than 70.16% of its industry peers.
A Quick Ratio of 1.44 indicates that ITI should not have too much problems paying its short term obligations.
ITI's Quick ratio of 1.44 is on the low side compared to the rest of the industry. ITI is outperformed by 62.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.44
ITI Yearly Current Assets VS Current LiabilitesITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

ITI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.67%, which is quite impressive.
ITI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -34.58% yearly.
Looking at the last year, ITI shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
The Revenue has been growing by 13.01% on average over the past years. This is quite good.
EPS 1Y (TTM)116.67%
EPS 3Y-34.58%
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y13.67%
Revenue growth 5Y13.01%
Sales Q2Q%5.13%

3.2 Future

Based on estimates for the next years, ITI will show a very strong growth in Earnings Per Share. The EPS will grow by 101.85% on average per year.
Based on estimates for the next years, ITI will show a quite strong growth in Revenue. The Revenue will grow by 12.26% on average per year.
EPS Next Y159.71%
EPS Next 2Y118.21%
EPS Next 3Y101.85%
EPS Next 5YN/A
Revenue Next Year10.08%
Revenue Next 2Y11.82%
Revenue Next 3Y12.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ITI Yearly Revenue VS EstimatesITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
ITI Yearly EPS VS EstimatesITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

ITI is valuated quite expensively with a Price/Earnings ratio of 239.67.
The rest of the industry has a similar Price/Earnings ratio as ITI.
ITI is valuated expensively when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 21.57, the valuation of ITI can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ITI indicates a somewhat cheap valuation: ITI is cheaper than 70.16% of the companies listed in the same industry.
ITI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 239.67
Fwd PE 21.57
ITI Price Earnings VS Forward Price EarningsITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ITI.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ITI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 235.51
EV/EBITDA 55.92
ITI Per share dataITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

ITI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ITI's earnings are expected to grow with 101.85% in the coming years.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y118.21%
EPS Next 3Y101.85%

0

5. Dividend

5.1 Amount

ITI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Iteris Incorporated New

NASDAQ:ITI (10/31/2024, 8:13:36 PM)

Premarket: 7.19 0 (0%)

7.19

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners69.2%
Inst Owner Change-84.5%
Ins Owners3.66%
Ins Owner Change0%
Market Cap309.46M
Analysts46.67
Price Target7.34 (2.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-89.39%
Min EPS beat(2)-100%
Max EPS beat(2)-78.79%
EPS beat(4)1
Avg EPS beat(4)-47.55%
Min EPS beat(4)-100%
Max EPS beat(4)32.01%
EPS beat(8)3
Avg EPS beat(8)4.7%
EPS beat(12)3
Avg EPS beat(12)-309.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)2.58%
Revenue beat(4)2
Avg Revenue beat(4)1.48%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)3.89%
Revenue beat(8)6
Avg Revenue beat(8)4.6%
Revenue beat(12)6
Avg Revenue beat(12)2.15%
Revenue beat(16)8
Avg Revenue beat(16)1.61%
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)12.49%
EPS NQ rev (3m)-47.06%
EPS NY rev (1m)1.88%
EPS NY rev (3m)-38.64%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 239.67
Fwd PE 21.57
P/S 1.78
P/FCF 235.51
P/OCF 83.41
P/B 4.4
P/tB 9.33
EV/EBITDA 55.92
EPS(TTM)0.03
EY0.42%
EPS(NY)0.33
Fwd EY4.64%
FCF(TTM)0.03
FCFY0.42%
OCF(TTM)0.09
OCFY1.2%
SpS4.05
BVpS1.63
TBVpS0.77
PEG (NY)1.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 1.99%
ROCE 1.39%
ROIC 1.26%
ROICexc 1.71%
ROICexgc 4.57%
OM 0.64%
PM (TTM) 0.8%
GM 37.38%
FCFM 0.75%
ROA(3y)-5.51%
ROA(5y)-2.81%
ROE(3y)-9.55%
ROE(5y)-4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y41.57%
ROICexcg growth 5YN/A
ROICexc growth 3Y34.52%
ROICexc growth 5YN/A
OM growth 3Y11.09%
OM growth 5YN/A
PM growth 3Y-40.46%
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5Y-0.15%
F-Score8
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 59.44%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 72.01%
Profit Quality 94.06%
Current Ratio 1.77
Quick Ratio 1.44
Altman-Z 3.69
F-Score8
WACC9.39%
ROIC/WACC0.13
Cap/Depr(3y)59.96%
Cap/Depr(5y)55.27%
Cap/Sales(3y)1.51%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.67%
EPS 3Y-34.58%
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y159.71%
EPS Next 2Y118.21%
EPS Next 3Y101.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y13.67%
Revenue growth 5Y13.01%
Sales Q2Q%5.13%
Revenue Next Year10.08%
Revenue Next 2Y11.82%
Revenue Next 3Y12.26%
Revenue Next 5YN/A
EBIT growth 1Y114.75%
EBIT growth 3Y26.28%
EBIT growth 5YN/A
EBIT Next Year275.63%
EBIT Next 3Y96.04%
EBIT Next 5YN/A
FCF growth 1Y108.39%
FCF growth 3Y17.68%
FCF growth 5YN/A
OCF growth 1Y126.16%
OCF growth 3Y20.58%
OCF growth 5YN/A